Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug composition for reducing blood sugar and blood fat and curing diabetes

A technology for diabetes and composition, applied in the field of pharmaceutical compositions for reducing blood sugar and blood lipids and treating diabetes, can solve the problems of high cost and selling price, few action targets, lack of links, etc. The effect of lowering blood sugar and blood lipids

Inactive Publication Date: 2009-11-11
BEIJING LIQIANQIU SCI & TECH DEV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] There are many types of medicines or health care products currently used to lower blood sugar and blood lipids, but there are few targets and links, which need to be improved, and there are many medicines with side effects, and the cost and price are very high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug composition for reducing blood sugar and blood fat and curing diabetes
  • Drug composition for reducing blood sugar and blood fat and curing diabetes

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Yam 7000mg,

[0027] Coptidis 2300mg,

[0028] Vitamin B 1 3 mg,

[0029] Vitamin B 2 3 mg,

[0030] Vitamin B 6 2 mg,

[0031] Vitamin B 12 0.003mg,

[0032] Folic acid 0.3mg,

[0033] Zinc lactate (calculated as trace element zinc) 10mg,

[0034] Sodium selenate (calculated as trace element selenium) 0.02mg,

[0035] Chromium nicotinate (calculated as trace element chromium) 0.1mg,

[0036] Vitamin E (calculated as α-tocopherol equivalent) 10mg α-TE.

[0037] The above components were further uniformly mixed with appropriate amounts of additives such as magnesium aluminosilicate, polysolvate 60 and propylene glycol, and the resulting mixture was evenly filled into capsules to obtain 9 capsules, 3 times a day, 3 capsules each time .

Embodiment 2

[0039] Yam 7500mg,

[0040] Coptidis 2500mg,

[0041] Vitamin B 1 3 mg,

[0042] Vitamin B 2 3 mg,

[0043] Vitamin B 6 2 mg,

[0044] Vitamin B 12 0.003mg,

[0045] Folic acid 0.3mg,

[0046] Niacinamide 10mg,

[0047] Zinc lactate (calculated as trace element zinc) 8mg,

[0048] Sodium selenate (calculated as trace element selenium) 0.02mg,

[0049] Chromium yeast (calculated as trace element chromium) 0.02mg,

[0050] Vitamin E (calculated as α-tocopherol equivalent) 10mg α-TE.

[0051] The above components were further uniformly mixed with appropriate amounts of additives such as magnesium aluminosilicate, polysolvate 60 and propylene glycol, and the resulting mixture was evenly filled into capsules to obtain 9 capsules, 3 times a day, 3 capsules each time .

Embodiment 3

[0053] Yam 8000mg,

[0054] Coptidis 4500mg,

[0055] Vitamin B 1 3 mg,

[0056] Vitamin B 2 3 mg,

[0057] Vitamin B 6 2 mg,

[0058] Vitamin B 12 0.003mg,

[0059] Folic acid 0.3mg,

[0060] Niacinamide 10mg,

[0061] Zinc lactate (calculated as trace element zinc) 10mg,

[0062] Sodium selenate (calculated as trace element selenium) 0.02mg,

[0063] Chromium yeast (calculated as trace element chromium) 0.02mg,

[0064] Sodium molybdate (calculated as trace element molybdenum) 0.03mg,

[0065] Vitamin E (calculated as α-tocopherol equivalent) 10mg α-TE.

[0066] The above components were further uniformly mixed with appropriate amounts of additives such as magnesium aluminosilicate, polysolvate 60 and propylene glycol, and the resulting mixture was evenly filled into capsules to obtain 9 capsules, 3 times a day, 3 capsules each time .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a drug composition for reducing blood sugar and blood fat and curing diabetes. The drug composition comprises common yam rhizome, golden thread, composite vitamin B, vitamin E, and trace elements of zinc, selenium, chromium and molybdenum. The drug composition is applicable to the crowds with high blood sugar, high blood fat and diabetes, is very effective in reducing blood sugar and blood fat and curing diabetes and can be applied for a long time or applied according to the course of the treatment.

Description

Technical field: [0001] The invention relates to the technical field of medicine and health products; especially a pharmaceutical composition for lowering blood sugar and blood fat and treating diabetes. Background technique: [0002] The composition comprises yam, coptis, complex vitamin B, vitamin E and trace elements zinc, selenium, chromium and molybdenum. [0003] Yam is a kind of natural Chinese herbal medicine for invigorating the spleen and nourishing qi, which is both food and medicine. It has the effects of strengthening the spleen, nourishing the lungs, strengthening the kidney, and benefiting the essence; , Consumption and thinness, lack of food and burnout embolism; and chronic nephritis, enuresis in children, women's leukorrhagia, etc.; modern pharmacological research has confirmed that yam has the following pharmacological effects: 1. Significant hypoglycemic effect; 2. Anti-aging effect; 3. Antioxidant effect; 4. Hypoxia resistant effect; 5. Function of regu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8945A61P3/06A61P3/10A61K31/191A61K31/197A61K31/355A61K31/4188A61K31/4415A61K31/455A61K31/51A61K31/519A61K31/525A61K31/714A61K33/04A61K33/24
Inventor 陈欣晶
Owner BEIJING LIQIANQIU SCI & TECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com